Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Perspective Therapeutics (CATX) Invested Capital (2016 - 2025)

Perspective Therapeutics (CATX) has disclosed Invested Capital for 15 consecutive years, with $207.0 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 28.77% to $207.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $207.0 million through Dec 2025, down 28.77% year-over-year, with the annual reading at $207.0 million for FY2025, 28.77% down from the prior year.
  • Invested Capital hit $207.0 million in Q4 2025 for Perspective Therapeutics, down from $242.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $341.0 million in Q2 2024 to a low of $54.6 million in Q4 2022.
  • Historically, Invested Capital has averaged $154.6 million across 5 years, with a median of $103.7 million in 2023.
  • Biggest five-year swings in Invested Capital: skyrocketed 1190.66% in 2021 and later decreased 28.77% in 2025.
  • Year by year, Invested Capital stood at $64.4 million in 2021, then decreased by 15.14% to $54.6 million in 2022, then skyrocketed by 37.58% to $75.2 million in 2023, then surged by 286.63% to $290.7 million in 2024, then fell by 28.77% to $207.0 million in 2025.
  • Business Quant data shows Invested Capital for CATX at $207.0 million in Q4 2025, $242.2 million in Q3 2025, and $265.7 million in Q2 2025.